Comparison of docetaxel/cisplatin dosages of 75/60 and 60/60 mg/m(2) for the treatment of non-small cell lung cancer

A combination of docetaxel (D) and cisplatin (P) is one of the standard regimens for the initial treatment of advanced non-small cell lung cancer (NSCLC). Yet, the toxicity of D administered at 75 mg/m(2) in three weekly doses to patients is a concern. The aim of this study was to assess the efficac...

Full description

Saved in:
Bibliographic Details
Published inExperimental and therapeutic medicine Vol. 4; no. 2; pp. 317 - 322
Main Authors Kim, Kyu-Sik, Oh, In-Jae, Ban, Hee-Jung, Cho, Hyun-Ju, Kwon, Yong-Soo, Kim, Yu-Il, Lim, Sung-Chul, Na, Kook-Joo, Song, Sang-Yun, Choi, Song, Choi, Yoo-Duk, Kim, Young-Chul
Format Journal Article
LanguageEnglish
Published Greece 01.08.2012
Online AccessGet full text

Cover

Be the first to leave a comment!
You must be logged in first